“Episode 122: The Pathway to Sustainable Market Share for Pharma, and Other Life Sciences Companies with Dave Dierk of Aventria Health Group”
by Stacey Richter
“Episode 122: The Pathway to Sustainable Market Share for Pharma, and Other Life Sciences Companies with Dave Dierk of Aventria Health Group”
by Stacey Richter
00:00 Comparing Pharma and Life Sciences to Tech Companies is like comparing apples to oranges.
03:15 “People are hedging their bets relative to where the volume sits.”
03:30 “What does inviting less risk mean?”
04:20 Making informed decisions based on Market Shift Data.
06:20 The doubling number of customers intending to adopt Value-Based Care Reimbursement Initiatives.
06:50 “Timing is what’s paramount here.”
07:30 Customers don’t only want to talk about brands, they want to talk Patient Care and Optimizing Outcomes.
08:10 “How are you Customer-Centric if you’re leading every conversation with the brand?”
10:00 Patient Care, Patient Outcomes, Market Share, Profitability and Reimbursement.
13:15 “Don’t presume that your timeline equates to their timeline.”
14:30 “What is the most conservative approach?”
14:50 “It’s a question of When, and To What Degree?”
17:00 The best way forward with Evidence-Based Pathways.
19:45 “Pharma does have a lot to offer.”
21:30 “Is there a Point of Prescribing?”
23:30 You can find out more information at aventriahealth.com.